Modulation of erm methyltransferase activity by peptides derived from phage display

Antimicrob Agents Chemother. 2000 Jul;44(7):1961-3. doi: 10.1128/AAC.44.7.1961-1963.2000.

Abstract

Combinatorial peptide display on phage M13 protein pIII was used to discover peptide sequences that selectively bind to ErmC' methyltransferase from Bacillus subtilis. One peptide, Ac-LSGVIAT-NH(2), inhibited methylation in vitro with a 50% inhibitory concentration of 20 microM. Interestingly, the set of six peptides which inhibited ErmC' stimulated ErmSF, a homologous methyltransferase from Streptomyces fradiae. Thus, Ac-LSGVIAT-NH(2) may not act directly at the catalytic center of ErmC', but may modulate its activity by binding at a structurally unrelated, but functionally linked, site.

MeSH terms

  • Bacillus subtilis / drug effects
  • Bacillus subtilis / enzymology*
  • Catalysis
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors / analysis
  • Enzyme Inhibitors / pharmacology*
  • Methylation
  • Methyltransferases / antagonists & inhibitors
  • Methyltransferases / metabolism*
  • Peptide Library
  • Peptides / analysis
  • Peptides / pharmacology*

Substances

  • Enzyme Inhibitors
  • Peptide Library
  • Peptides
  • Methyltransferases
  • rRNA (adenosine-O-2'-)methyltransferase